Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Koenigsmann

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Transfusion|April 24, 2004
The role of diagnosis in patients failing peripheral blood progenitor cell mobilizationMichael Koenigsmann, Kathleen Jentsch-Ullrich, Martin Mohren, et al.
Annals of Hematology|March 9, 2006
Zygomycoses in patients with acute leukaemiaEnrico Schalk, Martin Mohren, Kathleen Jentsch-Ullrich, et al.
Haematologica|May 12, 2004
Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinibKathleen Jentsch-Ullrich, Antje-Friederike Pelz, Holger Braun, et al.
Journal of Clinical Medicine|October 28, 2023
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms-Real-World Data from the German Noninterventional Study EXCALIBURFelicitas Schulz, Ulrich Hauch, Sandra Ketzler-Henkel, et al.
Annals of Hematology|May 12, 2026
Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study)Martin Griesshammer, Eyck von der Heyde, Rudolf Schlag, et al.
Hematological Oncology|May 4, 2021
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic NeoplasmsWolfgang Knauf, Wolfgang Abenhardt, Michael Koenigsmann, et al.
European Journal of Haematology|February 3, 2018
Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practiceMarcel Reiser, Steffen Dörfel, Manfred Hensel, et al.
BMC Immunology|July 1, 2020
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacementRudolf Weide, Roland Schnell, Christof Schardt, et al.
Leukemia & Lymphoma|June 30, 2004
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)Michael Koenigsmann, Wolfgang Knauf, Michael Herold, et al.
Molecular and Clinical Oncology|July 24, 2014
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphomaMichael Schmitt, Rudolf Trenschel, Herbert G Sayer, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Transfusion|April 24, 2004
The role of diagnosis in patients failing peripheral blood progenitor cell mobilizationMichael Koenigsmann, Kathleen Jentsch-Ullrich, Martin Mohren, et al.
Annals of Hematology|March 9, 2006
Zygomycoses in patients with acute leukaemiaEnrico Schalk, Martin Mohren, Kathleen Jentsch-Ullrich, et al.
Haematologica|May 12, 2004
Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinibKathleen Jentsch-Ullrich, Antje-Friederike Pelz, Holger Braun, et al.
Journal of Clinical Medicine|October 28, 2023
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms-Real-World Data from the German Noninterventional Study EXCALIBURFelicitas Schulz, Ulrich Hauch, Sandra Ketzler-Henkel, et al.
Annals of Hematology|May 12, 2026
Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study)Martin Griesshammer, Eyck von der Heyde, Rudolf Schlag, et al.
Hematological Oncology|May 4, 2021
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic NeoplasmsWolfgang Knauf, Wolfgang Abenhardt, Michael Koenigsmann, et al.
European Journal of Haematology|February 3, 2018
Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practiceMarcel Reiser, Steffen Dörfel, Manfred Hensel, et al.
BMC Immunology|July 1, 2020
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacementRudolf Weide, Roland Schnell, Christof Schardt, et al.
Leukemia & Lymphoma|June 30, 2004
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)Michael Koenigsmann, Wolfgang Knauf, Michael Herold, et al.
Molecular and Clinical Oncology|July 24, 2014
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphomaMichael Schmitt, Rudolf Trenschel, Herbert G Sayer, et al.
Pageof 3